In that cohort, patients with FEN1-high and YY1-low expression had both statistically significantly poor overall and disease-free postoperative survivals, a fact suggesting that FEN1 and YY1 might have inverse impact on the survival of breast cancer patients. The gene discussed is YY1; the disease is breast carcinoma.